2 research outputs found
Haplotype Analysis of the First A4V-SOD1 Spanish Family: Two Separate Founders or a Single Common Founder?
A4V; SOD1; Esclerosi lateral amiotr貌ficaA4V; SOD1; Esclerosis lateral amiotr贸ficaA4V; SOD1; Amyotrophic lateral sclerosisDespite the genetic heterogeneity reported in familial amyotrophic lateral sclerosis (ALS) (fALS), Cu/Zn superoxide-dismutase (SOD1) gene mutations are the second most common cause of the disease, accounting for around 20% of all families (ALS1) and isolated sporadic cases (sALS). At least 186 different mutations in the SOD1 gene have been reported to date. The possibility of a single founder and separate founders have been investigated for D90A (p.D91A) and A4V (p.A5V), the most common mutations worldwide. High-throughput single nucleotide polymorphism genotyping studies have suggested two founders for A4V (one for the Amerindian population and another for the European population) although the possibility that the two populations are descended from a single ancient founder cannot be ruled out. We used 15 genetic variants spanning the human chromosome 21 from the SOD1 gene to the SCAF4 gene, comparing them with the population reference panels, to demonstrate that the first A4V Spanish pedigree shared the genetic background reported in the European population.This study has been supported by Instituto de Salud Carlos III (grant numbers PIS-FEDER PI16/01673 and PI19/00593). JG and JV-T are the recipients of grant 2017SGR00939 from Ag猫ncia de Gesti贸 d鈥橝juts Universitaris i de Recerca (AGAUR) of the Generalitat de Catalunya
Regulaci贸n de la movilidad celular por Profilina 1
Mi proyecto de tesis se basaba en el estudio del papel de profilina 1 en la formaci贸n de lamelas, para ello generamos una prote铆na recombinante y transducible, con el objetivo de poder modificar los niveles end贸genos de profilina.
Objetivos:
i-caracterizaci贸n bioqu铆mica los tres sitios de union conocidos de la prote铆na de transducci贸n, el sitio de uni贸n a fosfo-inocitoles (PIP), el de uni贸n a actina (Ac) y el de uni贸n a poli-prolinas (PLP).
ii-estudio de la polimerizaci贸n in-vitro de actina - PTD4-Profilina1
iii-estudio de las prote铆nas componentes de lamelas inducidas por PTD4-Profilina1.
Plan de trabajo:
i-Para comprobar la funcionalidad los 3 sitios de uni贸n fueron necesarias las primeras 6 semanas, ya que en primer lugar hab铆a que expresar y purificar el peptido Srv2, necesario para el ensayo de PLP. En segundo lugar, se obtuvieron los datos de las concentraciones adecuadas de l铆pidos para el ensayo de fosfo-inocitoles y por ultimo, se purifico la actina necesaria para el ensayo de uni贸n a actina. Una vez establecida la funcionalidad de la prote铆na, se procedi贸 a:
ii-el estudio de polimerizaci贸n in-vitro, que llevo 2 semanas. Demostrando que in-vitro era capaz de inhibir la polimerizaci贸n de una manera similar a la end贸gena. Una vez terminados estos ensayos, se procedio a:
iii-la caracterizaci贸n inmunohistoqu铆mica de las prote铆nas componentes de la lamela que fue llevado a cabo en 4 semanas. Para ello se usaron anticuerpos contra: alfa-actinina, talina, vinculina, ENA/Vasp y paxillina.
Conclusiones:
i-las propiedades bioqu铆micas de la PTD4-Profilina1 son similares a las de la profilina end贸gena.
ii-los estudios de polimerizaci贸n indican que la polimerizaci贸n se produce de manera similar a la endogena.
iii-los ensayos de inmunohistoqu铆mica sugieren que, talina esta ausente y que las dem谩s est谩n presentes aunque en menor concentraci贸n y con otra distribuci贸n comparadas con los controles.My thesis project is based in the study of roll of profilin lamella formation. To achieve it, we developed a recombinant and transducible protein called PTD4-Pfn1. With this protein, we are able to modified the intracellular protein levels in a fisiological range .
During the time between the grant submission and the beginning of the stay we developed in the objectives, and for an explicit petition of the researcher director of the acceptor center, we changed the objectives in the following:
Objetives
i-biochemical characterization of the three known binding sites of the of the PTD4-Profilin1 protein transduction, the phosphor-inocitol, actin and poly-prolines binding sites.
ii-in-vitro study of the actin polymerization in presence of PTD4-Profilin1.
iii-study of the components proteins in the formation of the lamellas PTD4-Profilin induced.
Planning
i-To test the three binding sites 6 weeks were neccesary. In these weeks we purified the peptides necessary to test the poly-proline binding sites, the Srv2. We also tested the best lipids concentration to the phosphor-inocitol binding assay. Finally, we prepared the actin necessary to the actin binding assay. Once established the protein functionality, we proceed to the following experiments:
ii- the in vivo actin polylerization assay was performed in 2 weeks. And:
iii-the inmuno-hystochemical characterization of the proteins of the PTD4-Profilin induced was performed in 4 weeks. For this propouse ee used antibodies against alfa-actinin, talin, vinculin, ENA/Vasp y paxillin.
Conlusions
i-the biochemical properties of PTD4-Profilin1 are similars to the endogen profilin.
ii-Lo studies suggest that the actin polymerization induced by PTD4-Profilin1 is similar to the promoted by the endogen profilin1
iii-the hystochemical assays suggest that talin is absent and the others, alfa-actinin, vinculin, ENA/Vasp and paxillin are present but il low concentration and in a different distribution